Introduction
ISS are short oligonucleotides (ODN) that mimic the innate immune response to microbial DNA 1 . ISS contain one or more CpG dinucleotide-containing motifs with unmethylated cytosine residues and are recognized by TLR-9, one of a family of receptors prominent in innate responses to microbial pathogens 2, 3 . TLR-9 expression is not widely distributed and ISS responsive cells in human PBMC are limited to B cells and PDC. ISS activate B cells to proliferate, secrete IL-6 and differentiate to plasma cells 4 . PDC respond to ISS by secreting type I interferons, TNF-α and, upon signaling through CD40, IL-12 2, 5 . In both cell types, ISS are potent enhancers of antigen-presenting cell function and induce key costimulatory molecules, such as CD40, CD80 and CD86 6 . In mixed cell populations, such as human PBMC, the direct response to ISS initiates a cascade of secondary responses, including activation of macrophages and NK cells and the induction of IFN-γ and a wide range of other cytokines and chemokines characteristic of inflammatory responses [6] [7] [8] [9] [10] .
At least three classes of ISS can be distinguished on the basis of both structure and function. Uniformly modified phosphorothioate (PS) ISS, termed CpG-B strongly activate B cells, but are weak stimulators of IFN-α from human PBMC. Phosphodiester (PO)-linked sequences flanked by PS-linked poly-G ends, termed CpG-A ISS, in contrast are potent inducers of IFN-α and IFN-γ but are weak activators of B cells 11 . Recently a third class of ISS has been defined, termed CpG-C. CpG-C ISS retain distinctive properties of both CpG-A and B ISS with respect to IFN-α production and B cell activation 6 . Preliminary data have
shown that ISS affect PDC survival, maturation and cytokine production but the differential properties of these ISS on PDC is otherwise undefined 5, 6, 12 .The efficient activation of APC and induction of IL-12, IFN-α and IFN-γ explains the potent ability of ISS to act as a strong 3 only.
For personal use at PENN STATE UNIVERSITY on February 22, 2013 . bloodjournal.hematologylibrary.org From Th1 polarizing adjuvant 13 . Besides inducing Th1 responses, administration of ISS mixed or covalently linked to antigens can inhibit Th2 responses [14] [15] [16] [17] and stimulate CD8 T cell responses 7 . These activities have stimulated much interest in the clinical use of ISS as a vaccine adjuvant and in the treatment of allergy, asthma, cancer and infectious diseases, and clinical trials are currently being conducted in all of these disease areas.
IL-10 is a potent anti-inflammatory cytokine that can act as a feedback regulator of the inflammatory response to many microbial stimuli 18 . IL-10 can be produced by a number of different cell types and can inhibit both Th1 and Th2 responses by affecting APC function and DC maturation [18] [19] [20] . IL-10 inhibits activation and induces death of PDC in vitro and can reduce PDC-derived IFN-α production in virus-activated PBMC [21] [22] [23] . Moreover, it was recently shown in mice that very low levels of IL-10 can inhibit the DC response to ISS activation both in vitro and in vivo 24 . IL-10 is induced by ISS, but its overall role in regulating the specific activities of ISS on PDC has not been studied. The varied effects of IL-10 are likely to have significance for the clinical application of ISS, as a number of the target disease states, especially cancer and chronic infection, are characterized by variable, often elevated IL-10 levels 18 .
In this paper, we show important differences in the response of PDC to the three different classes of ISS and use these differences to explore the range of effects of IL-10 on ISS activity. Some activities of ISS appear to be much more sensitive to high levels of IL-10 and this may influence the choice of specific classes of ISS in disease states marked by elevations in IL-10.
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Materials and methods

Medium and ISS Oligonucleotides
Isolated cells were cultured in supplemented RPMI 1640 (Bio-Whitaker, Santa Rosa, CA) as previously described 6 . All oligodeoxynucleotides were prepared as previously 
Cytokines and Antibodies
Human recombinant IL-3 and IL-10 were purchased from R&D systems (Minneapolis, duplicate with ODN at 20 µg/ml, with hIL-10 (10 ng/ml) or anti IL-10R (2.5 µg/ml).
Isolation and In Vitro Stimulation of Blood PDC
PDC were isolated using BDCA-4 enrichment as previously described 6 . Purity was routinely greater than 97 %. PDC experiments were conducted with 3-5x10 4 
CFSE Labeling and In Vitro Naïve T cell Stimulation
Naïve CD4 + CD45RA + T cells were prepared using a two-step approach using 
ELISA and Intracellular Staining
IFN-α production was assayed by ELISA (PBL Biomedical Laboratories, Piscataway, NJ). IFN-γ and IL-12p40 were assayed with CytoSet antibody pairs (BioSource, Camarillo, CA). All kits and antibody pairs were used according to manufacturers' instructions. For intracellular flow cytometry analysis, PDC were cultured as described in the presence of CD40L-transfected L-cells for 10h followed by addition of Brefeldin A (10ng/ml) for 2h.
The cells were harvested, stained with anti-CD86, -BDCA2, -BDCA4, or CD123 and then fixed with 2% paraformaldehyde (SIGMA, St Louis, MO), permeabilized with 0.5% saponin and stained with the anti-IL-12p40/p70 and anti-IFN-α as described 25 .
Real-time Quantitative PCR (TaqMan) Analysis
Human PBMC were stimulated with ISS for 24h. RNA was isolated and converted to cDNA and PCR reactions were performed as described 6 . The human sequences for synthesized primers and the calculation method were as previously described 6 . Briefly, threshold cycle (CT) values for each gene were normalized to the housekeeping gene HPRT using the formula 1.8(HKG-GENE)(1000), where HKG is the mean CT of triplicate HPRT runs, GENE is the mean CT of duplicate runs of the gene of interest, and 1000 is arbitrarily chosen as a factor to bring all values above 0. For personal use at PENN STATE UNIVERSITY on February 22, 2013. bloodjournal.hematologylibrary.org From compared to CD86 expression after stimulation with CD40L and C274, conditions that stimulate both IL-12 and IFN-α (Figure 2A and 3A) . Strikingly, IFN-α producing cells were almost exclusively found in the CD86 negative population while IL-12 positive cells were mostly CD86 positive ( Figure 3B ). These findings suggest that PDC initially can produce IFN-α in response to ISS stimulation, but IFN-α is lost and IL-12 production acquired as the cells undergo maturation into DC.
IL-10 is Cytotoxic for ISS-Activated PDC and this effect is Counter-Balanced by IFN-α
IL-10 has been described to induce PDC death, whereas ISS have been shown to induce PDC survival 12, 21, 22 . Indeed, all ISS tested, as well as IL-3, strongly enhanced PDC survival. This survival activity was CpG specific, as PDC cultured with control oligonucleotides died rapidly in vitro ( Figure 4A ). PDC stimulated with the CpG-B-ISS 1018 were dramatically affected by IL-10 ( Figure 4B ), while PDC stimulated with CpG-A-ISS D19 and CpG-C ISS C274 were resistant to IL-10 ( Figure 4C and D) . Addition of anti-IL-10R did not increase survival of PDC treated with ISS (data not shown). Both D19 and C274 can induce high levels of IFN-α, which is known to be a strong autocrine PDC survival factor 26 . Blockage of IFN-α in the culture indeed rendered D19-stimulated PDC sensitive to IL-10 ( Figure 4E ), which demonstrated that IFN-α is counteracting the cytotoxic effect of IL-10.
ISS-induced Maturation of PDC is not Inhibited by IL-10
One of the best described properties of IL-10 is the inhibition of co-stimulatory molecule expression on many types of antigen presenting cells 18 . As many ISS have been shown to induce CD80 and CD86 expression on PDC, the potential inhibition of that process by IL-10 10 only.
For personal use at PENN STATE UNIVERSITY on February 22, 2013. bloodjournal.hematologylibrary.org From was examined. All three classes of ISS induced CD80 and CD86 expression although the CpG-A ISS (D19) was a much weaker inducer than CpG-B ISS (1018) and CpG-C ISS (C274) ( Figure 5A ). Costimulation with CD40L, which is likely to occur when PDC encounter T cells, enhanced the overall stimulation, but showed similar differences among sequences (data not shown and Figure 5B ). Unexpectedly, IL-10 produced no effect on the induction of CD80 or CD86 with any of the ISS tested ( Figure 5B ). Similar observations were obtained when PDC were stimulated in absence of CD40L (data not shown), except that the 1018-stimulated group was not informative due to cell death induced by IL-10 ( Figure 4A ).
IL-10 does not Regulate T cell Activation by ISS-Activated PDC.
To address whether IL-10 can affect T cell priming by ISS-stimulated PDC, allogeneic T cells were labeled with CFSE and cultured with or without IL-10 for 3 days with PDC previously activated with ISS and CD40L. PDC cultured for 24 hrs with CpG-B or CpG-C ISS very potently stimulated T cells (82% and 77% CFSE low T cells, respectively), whereas PDC cultured with the CpG-A sequence, D19, were much less active ( Figure 6A ). This corresponds with the reduced activity of CpG-A ISS for the induction of IL-12, CD80 and CD86 (Figures 2 and 5) . The addition or removal of IL-10 at the time of the co-culture of the 1018-activated PDC and allogeneic T cells did not affect the PDC priming capacity ( Figure   6B ). Similar data were observed using the other classes of ISS (data not shown). This suggests that IL-10 regulates PDC-T cell interaction by acting on the PDC and not by impairing subsequent T cell activation.
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For personal use at PENN STATE UNIVERSITY on February 22, 2013. bloodjournal.hematologylibrary.org From Discussion IL-10 has been described as a key player in striking a balance between pathology and protection and is found elevated in numerous clinical situations, such as cancer and infectious disease. IL-10 is believed to be a major cause of ineffective immune response in these disease states and high levels of IL-10 is often a negative prognostic factor for patient survival. We observed low IL-10 levels, 50 to 300 pg/ml, in supernatants of ISS-activated PBMC ( Figure 1A ), but these were sufficient to inhibit IFN-γ and IFN-γ inducible gene For personal use at PENN STATE UNIVERSITY on February 22, 2013. bloodjournal.hematologylibrary.org From Figure 6 only.
